Previous studies have shown that mutations of Per2 decrease the production of nitric oxide, vasodilatory prostaglandin(s) [19], myocardial adaptation to ischaemia [37] and mobilization of bone-marrow EPCs [18], all important to cardiovascular disease. The gene discussed is PER2; the disease is cardiovascular disorder.